Fifth Third Bancorp
MYGN icon

Fifth Third Bancorp’s Myriad Genetics MYGN Stock Holding History

Fifth Third Bancorp’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46K Sell
256
-3,182
-93% -$14.4K ﹤0.01% 4128
2026
Q1 		$15.5K Buy
3,438
+1,258
+58% +$6.55K ﹤0.01% 3579
2025
Q4 		$13.4K Buy
2,180
+131
+6% +$950 ﹤0.01% 2041
2025
Q3 		$14.8K Sell
2,049
-218
-10% -$1.29K ﹤0.01% 2017
2025
Q2 		$12K Sell
2,267
-44,222
-95% -$261K ﹤0.01% 1959
2025
Q1 		$412K Sell
46,489
-8,826
-16% -$106K ﹤0.01% 799
2024
Q4 		$758K Sell
55,315
-23,296
-30% -$430K ﹤0.01% 637
2024
Q3 		$2.15M Sell
78,611
-3,143
-4% -$85.1K 0.01% 461
2024
Q2 		$2M Buy
81,754
+1,139
+1% +$25K 0.01% 458
2024
Q1 		$1.72M Buy
80,615
+2,812
+4% +$60.5K 0.01% 486
2023
Q4 		$1.49M Buy
77,803
+3,695
+5% +$63.9K 0.01% 511
2023
Q3 		$1.19M Sell
74,108
-386
-0.5% -$7.34K 0.01% 542
2023
Q2 		$1.73M Buy
74,494
+5,324
+8% +$116K 0.01% 477
2023
Q1 		$1.61M Buy
69,170
+2,835
+4% +$57.6K 0.01% 482
2022
Q4 		$963K Buy
66,335
+7,835
+13% +$146K ﹤0.01% 562
2022
Q3 		$1.12M Buy
58,500
+33,539
+134% +$770K 0.01% 529
2022
Q2 		$454K Buy
24,961
+3,142
+14% +$65.2K ﹤0.01% 707
2022
Q1 		$550K Buy
21,819
+4,795
+28% +$123K ﹤0.01% 697
2021
Q4 		$470K Buy
17,024
+3,056
+22% +$88.5K ﹤0.01% 741
2021
Q3 		$451K Buy
13,968
+2,909
+26% +$96.6K ﹤0.01% 724
2021
Q2 		$338K Sell
11,059
-1,555
-12% -$44.9K ﹤0.01% 812
2021
Q1 		$384K Buy
12,614
+987
+8% +$28K ﹤0.01% 765
2020
Q4 		$230K Buy
11,627
+4,302
+59% +$69.5K ﹤0.01% 883
2020
Q3 		$96K Buy
7,325
+295
+4% +$3.73K ﹤0.01% 1130
2020
Q2 		$80K Buy
7,030
+3,715
+112% +$52.8K ﹤0.01% 1159
2020
Q1 		$47K Buy
+3,315
New +$70K ﹤0.01% 1289
2016
Q3 		– Sell
-91
Closed -$3K – 2271
2016
Q2 		$3K Hold
91
– – ﹤0.01% 2064
2016
Q1 		$3K Hold
91
– – ﹤0.01% 2102
2015
Q4 		$4K Hold
91
– – ﹤0.01% 2268
2015
Q3 		$3K Hold
91
– – ﹤0.01% 2493
2015
Q2 		$3K Sell
91
-187
-67% -$6.36K ﹤0.01% 2457
2015
Q1 		$10K Hold
278
– – ﹤0.01% 2008
2014
Q4 		$9K Sell
278
-281
-50% -$9.97K ﹤0.01% 1975
2014
Q3 		$22K Sell
559
-504
-47% -$18.8K ﹤0.01% 1734
2014
Q2 		$41K Sell
1,063
-7,688
-88% -$286K ﹤0.01% 1510
2014
Q1 		$299K Sell
8,751
-43,817
-83% -$1.36M ﹤0.01% 832
2013
Q4 		$1.1M Buy
52,568
+19,774
+60% +$500K 0.01% 568
2013
Q3 		$771K Sell
32,794
-1,078
-3% -$30.6K 0.01% 641
2013
Q2 		$910K Buy
+33,872
New +$982K 0.01% 609

Other funds holding MYGN

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
OAM
OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Fifth Third Bancorp's MYGN Position: Q2 2026 in Review

Fifth Third Bancorp reduced its Myriad Genetics (MYGN) stake by 93% in Q2 2026, selling an estimated $14.4K and leaving 256 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #4128.

Fifth Third Bancorp first reported a position in MYGN in Q2 2013 and has held it in 39 quarters since. The position peaked at $2.15M in Q3 2024. 52 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Fifth Third Bancorp held 256 shares of Myriad Genetics worth $1.46K as of Q2 2026.
  • Fifth Third Bancorp sold 3,182 Myriad Genetics shares in Q2 2026, an estimated $14.4K.
  • Myriad Genetics made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #4128 holding.
  • Fifth Third Bancorp first reported a position in Myriad Genetics in Q2 2013 and has held it in 39 quarters since.
  • Fifth Third Bancorp's Myriad Genetics position peaked at $2.15M in Q3 2024.
  • 52 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.